Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexrabeprazole sodium injection vs rabeprazole sodium injection for peptic ulcer bleeding
CTR20170066Phase 3Active
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexrabeprazole in upper gastrointestinal bleeding (UGIB), gastric ulcer, duodenal ulcer, sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Jan 2017; status: active.
02
Drugs
dexrabeprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on CTR20170066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170066.